Literature DB >> 15737196

Inhibition of cell proliferation by bacterial lipopolysaccharides in TLR4-positive epithelial cells: independence of nitric oxide and cytokine release.

Karin Müller-Decker1, Gwendolin Manegold, Herbert Butz, Detlef E Hinz, Dirk Hüttner, K Hartmut Richter, Matthias Tremmel, Rico Weissflog, Friedrich Marks.   

Abstract

Phylogenetically conserved toll-like receptors (TLR) recognize "pathogen-associated molecular patterns". Upon binding of ligands, TLR initiate innate immune response in immune and most likely epithelial cells. The TLR4 isoform is considered as a lipopolysaccharide (LPS) receptor. As shown here, a rat-tongue-derived epithelial cell line RTE2 expressed TLR4 mRNA and functional protein. LPS-treated RTE2 cells responded with the transient expression of inducible nitric oxide synthase (iNOS), an effector protein of TLR4 involved in the innate immune defense of monocytes. iNOS induction occurred along a nuclear factor-kappaB (NF-kappab)-dependent pathway and correlated with the increased production of NO. Moreover, LPS and lipid A were potent inhibitors of proliferation of RTE2 cells, of mouse keratinocytes, and mouse epidermis in vivo. The inhibition depended on lipid A structure, i.e., it was related to the endotoxin activity of LPS and at least in vitro was in part mediated by NF-kappaB. C57Bl/10 ScCr mice, lacking a functional TLR4, did not respond with growth inhibition, strongly suggesting a TLR4-mediated effect. RTE2 proliferation was also inhibited by transforming growth factor beta (TGFbeta) and tumor necrosis factor alpha (TNFalpha), whereas interferon gamma (IFNgamma) was a weak inhibitor. But the growth-inhibitory effect of LPS on RTE2 cells was not mediated by TNFalpha, TGFbeta, or NO. It is concluded that besides induction of innate immune responses, LPS specifically induces growth arrest in epithelial tongue cells and keratinocytes in vitro and in mouse epidermis in a TLR4-dependent but cytokine- and NO-independent manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737196     DOI: 10.1111/j.0022-202X.2004.23598.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

2.  Lipopolysaccharides attenuates growth of HS cells through the JNK pathway.

Authors:  Jinle Fu; Hao Peng
Journal:  Cytotechnology       Date:  2016-02-22       Impact factor: 2.058

3.  Differential innate immune cell signatures and effects regulated by toll-like receptor 4 during murine lung tumor promotion.

Authors:  Carla-Maria Alexander; Ka-Na Xiong; Kalpana Velmurugan; Julie Xiong; Ross S Osgood; Alison K Bauer
Journal:  Exp Lung Res       Date:  2016-04       Impact factor: 2.459

Review 4.  Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

5.  New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response.

Authors:  Sarah Moustafa; Dana N Joseph; Robert N Taylor; Shannon Whirledge
Journal:  Am J Reprod Immunol       Date:  2019-01-28       Impact factor: 3.886

6.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

7.  Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.

Authors:  Nabiha Yusuf; Tahseen H Nasti; Sreelatha Meleth; Craig A Elmets
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

8.  Chongcao-Shencha Attenuates Liver and Kidney Injury through Attenuating Oxidative Stress and Inflammatory Response in D-Galactose-Treated Mice.

Authors:  Cailan Li; Zhizhun Mo; Jianhui Xie; Lieqiang Xu; Lihua Tan; Dandan Luo; Hanbin Chen; Hongmei Yang; Yucui Li; Ziren Su; Zuqing Su
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-02       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.